InvestorsHub Logo
Followers 27
Posts 2850
Boards Moderated 0
Alias Born 10/17/2009

Re: None

Monday, 01/07/2013 8:03:41 AM

Monday, January 07, 2013 8:03:41 AM

Post# of 5881
IMUC
08:02 AM ImmunoCellular Therapeutics (IMUC) provides an update about the various cancer vaccines it's developing, saying it expects the Data Safety Monitoring Committee to conduct an interim safety and futility analysis of the Phase IIb trial of ICT-107, which targets glioblastoma antigens and cancer stem cells, early this year. (PR)